Advances in Novel Formulations for Drug Delivery / / Keservani著
| Advances in Novel Formulations for Drug Delivery / / Keservani著 |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2023.2 |
| Descrizione fisica | 1 online resource (576 pages) |
| Disciplina | 615.6 |
| Soggetto topico | Drug delivery systems |
| ISBN |
9781394167708
1394167709 9781394167692 1394167695 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- Preface -- Part I: Novel Drug Carriers and Therapeutics -- Chapter 1 Nanoarchitectured Materials: Their Applications and Present Scenarios in Drug Delivery -- 1.1 Introduction -- 1.2 Liposomes -- 1.3 Nanoparticles -- 1.3.1 Nanoparticles in Drug Delivery -- 1.4 Nanoemulsions -- 1.4.1 Advantages and Shortcomings of Nanoemulsions -- 1.4.2 Application of Nanoemulsion in Drug Delivery -- 1.5 Dendrimers -- 1.5.1 Synthesis of Dendrimers -- 1.5.2 Advantages of Dendrimers -- 1.5.3 Applications of Dendrimers in Drug Delivery -- 1.6 Aquasomes -- 1.6.1 Properties of Aquasomes -- 1.6.2 Application of Aquasomes in Drug Delivery -- 1.7 Nanogel -- 1.7.1 Properties of Nanogels -- 1.7.2 Nanogels in Drug Delivery -- 1.8 Quantum Dots -- 1.8.1 Applications of Quantum Dots in Drug Delivery -- 1.9 Carbon Nanotubes -- 1.9.1 Features of Carbon Nanotubes -- 1.9.2 Carbon Nanotubes in Drug Delivery -- References -- Chapter 2 Nanopharmaceuticals for Drug Delivery -- 2.1 Introduction -- 2.2 What Are Nanopharmaceuticals and What Do They Do? -- 2.3 Nanopharmaceuticals Importance -- 2.4 Nanotechnology -- 2.5 Pharmaceutical Companies and Nanotechnology -- 2.6 Applications and Advantages of Nanopharmaceuticals as Drug Carriers -- 2.7 Characteristics of Nanoparticles in Nanopharmaceuticals -- 2.7.1 Particle Size -- 2.7.2 Surface Properties of Nanoparticles -- 2.7.3 Drug Loading -- 2.7.4 Drug Release -- 2.8 Targeted Drug Delivery -- 2.9 Types of Nanoparticles -- 2.10 Nanoparticle Preparation Methods -- 2.11 Evaluation of Nanoparticles -- 2.12 Efficiency of Drug Entrapment -- 2.13 Particle Shape -- 2.14 Size of the Particles -- 2.15 Zeta Potential -- 2.16 Rise of Nanopharmaceuticals -- 2.17 Nanopharmaceuticals Approval Regulations (FDA Rules & -- Regulations) -- 2.18 Conclusions and Prospects for the Future -- References.
Chapter 3 Applications and Prospects of Nanopharmaceuticals Delivery -- 3.1 Introduction -- 3.2 Nanopharmaceuticals -- 3.3 Development of Nanopharmaceuticals -- 3.3.1 From Lab to the Marketplace -- 3.3.2 Techniques -- 3.3.3 Cost -- 3.3.4 Ethics -- 3.3.5 Nanopharmaceuticals Approval Regulations (FDA Rules & -- Regulations) -- 3.4 Clinical Applications of Nanotechnology -- 3.4.1 Diagnostic Applications -- 3.4.1.1 Detection -- 3.4.1.2 Protein Chips -- 3.4.1.3 Individual Target Probes -- 3.4.1.4 Nanotechnology as a Tool in Imaging -- 3.4.1.5 Sparse Cell Detection -- 3.4.2 Therapeutic Applications -- 3.4.2.1 Surfaces -- 3.4.2.2 Gene Delivery -- 3.4.2.3 Drug Delivery -- 3.4.2.4 Liposomes -- 3.4.2.5 Nanotechnology in Orthopedic Applications -- 3.4.2.6 Nanotechnology in Cardiac Therapy -- 3.4.2.7 Nanotechnology in Dental Care -- 3.4.2.8 Biomolecular Engineering -- 3.4.2.9 Biopharmaceuticals -- 3.5 Nanopharmaceuticals Delivery-Recent Applications -- 3.5.1 Nanoparticulate Systems for Vaccine -- 3.5.1.1 Polyanhydride-Based NPs -- 3.5.1.2 Biodegradable Synthetic PLGA NPs -- 3.5.1.3 Liposome-Based NPs -- 3.5.1.4 Polysaccharide-Based NPs -- 3.5.2 Chemotherapy -- 3.5.2.1 Increasing the Concentration of Chemotherapeutic Agents in Tumor Tissue -- 3.5.3 Drug/Gene Delivery -- 3.5.3.1 Nanoparticles Used in Drug Delivery System -- 3.5.3.2 Cellulose -- 3.6 Nanotechnology in Neurodegenerative Disorders Treatment -- 3.7 Future Perspective -- 3.8 Issues with Current Nanopharmaceutical Concepts -- 3.8.1 Large-Scale Manufacturing -- 3.8.2 Biological Challenges -- 3.8.3 Intellectual Property (IP) -- 3.8.4 Biocompatibility and Safety -- 3.8.5 Government Regulations -- 3.9 Conclusion -- References -- Chapter 4 Nanomedicine Regulation and Future Prospects -- 4.1 Introduction -- 4.2 Importance of Regulation of Nanomedicine. 4.3 Regulatory Challenges Faced by Nanomaterial in Medicine -- 4.3.1 Performing Various Functions -- 4.3.2 Nanomedicine Classification Issues -- 4.3.3 Variation in Size of the Particle -- 4.3.4 Manufacturing Process -- 4.3.5 Difficulties to Create CQA -- 4.3.6 Nanotoxicology and Cellular Response -- 4.3.7 Administering Right Doses -- 4.3.8 Pharmacokinetics -- 4.3.9 Developing Guidelines -- 4.4 Nanomedicine Future Aspects -- 4.5 Challenges that Threaten the Future of Nanomedicine -- 4.5.1 Financial Crisis -- 4.5.2 Lack of Confidence -- 4.5.3 Potential Dangers -- 4.5.4 Unsuccessful Patenting -- 4.5.5 Breakdowns in the Pharmaceuticals and Financial Markets -- 4.5.6 Limited Regulation -- 4.6 Future Prospects for Nanomedicine -- 4.6.1 Emerging Nanomaterials -- 4.6.2 Personalized Nanomedicine -- 4.6.3 Nanorobots and Nanodevices -- 4.6.4 Orthopedic Augmentations and Cytocompatibility -- 4.6.5 Cardiology and Nanotechnology -- 4.6.6 Cancer and Nanotechnology -- 4.6.7 NAPT -- 4.6.8 Gene, Protein, Lab-on-a-Chip Devices -- 4.6.9 Polymeric Nanoparticles in Medicine -- References -- Chapter 5 Nanotechnology Application in Drug Delivery for Medicinal Plants -- 5.1 Introduction -- 5.1.1 Nanodrug Delivery Systems (NDDS) -- 5.2 Nanoherbals -- 5.2.1 Cucuma longa (Cucurmin) -- 5.2.2 Gingko biloba -- 5.2.3 Artemisia -- 5.2.4 Silybum marianum-Silymarin -- 5.2.5 Salvia miltiorrhiza (Danshen) -- 5.2.6 Glycyrrhiza glabra (L.) -- 5.2.7 Camellia sinensis (Green tea) -- 5.2.8 Camptotheca acuminata -- 5.2.9 Leea indica -- 5.2.10 Ziziphus mauritiana (Malay apple) -- 5.2.11 Cuscuta chinensis -- 5.3 Conclusion -- References -- Chapter 6 Nanosystems Trends in Nutraceutical Delivery -- 6.1 Introduction -- 6.2 Classification of Nutraceuticals -- 6.3 Biopharmaceutical Issues Associated with Nutraceuticals -- 6.4 Nanosystems for Delivery of Nutraceuticals -- 6.4.1 Nanoemulsions. 6.4.2 Self-Emulsifying Systems -- 6.4.3 Solid Lipid Nanoparticles and Nanostructured Lipid Carriers -- 6.4.4 Liposomes -- 6.4.5 Polymeric Nanoparticles -- 6.4.6 Inorganic Nanoparticles -- 6.5 Challenges -- 6.6 Market Potential -- 6.7 Conclusion and Perspective -- References -- Chapter 7 Nanoencapsulated Systems for Delivery of Phytopharmaceuticals -- 7.1 Introduction -- 7.1.1 Nanoencapsulation Techniques in Phytopharmaceuticals -- 7.1.1.1 Physical-Chemical Techniques -- 7.1.1.2 Chemicals Techniques -- 7.1.1.3 Mechanical Techniques -- 7.1.2 Characterization of Nanoencapsulates -- 7.1.2.1 Morphological Characterization -- 7.1.2.2 Physicochemical Characterization -- 7.1.3 Nanoencapsulated Systems for Free Delivery of Phytopharmaceuticals -- 7.1.4 Studies to Evaluate Phytopharmaceuticals Nanoencapsulates -- 7.2 Conclusions -- References -- Chapter 8 Topical Drug Delivery Using Liposomes and Liquid Crystalline Phases for Skin Cancer Therapy -- 8.1 Introduction -- 8.2 Liposomes for Topical Application -- 8.2.1 Development of Liposomal Nanoparticles -- 8.3 Liquid Crystals and Liquid Crystalline Nanodispersions for Topical Application -- 8.3.1 Characterization Techniques -- 8.4 Physical Methods Applied to Nanoparticles Delivery -- 8.4.1 Sonophoresis -- 8.4.2 Microneedles -- 8.5 Conclusions and Perspectives -- Acknowledgements -- References -- Chapter 9 Vesicular Drug Delivery in Arthritis Treatment -- 9.1 Introduction -- 9.2 Skin Penetration Pathways -- 9.2.1 Intercellular Pathway -- 9.2.2 Transcellular Pathway -- 9.2.3 Appendgeal Pathway -- 9.3 Principles of Drug Permeation Through Skin -- 9.4 Problems Associated with Conventional Dosage Forms -- 9.5 Novel Treatment Strategies for Arthritis -- 9.5.1 Traditional Liposomes as Skin Drug Delivery Systems -- 9.5.2 Transferosomes (Ultradeformable Liposomes) as Skin Drug Delivery Systems. 9.5.3 Ethosomes as Skin Drug Delivery Systems -- 9.5.4 Niosomes as Skin Drug Delivery Systems -- 9.6 Conclusion and Future Perspectives -- References -- Chapter 10 Perspectives of Novel Drug Delivery in Mycoses -- 10.1 Introduction -- 10.2 Role of Conventional Drugs in Antifungal Therapy -- 10.3 Mechanism of Action of Conventional Antifungals -- 10.4 Summary of Nanoparticles and Their Role in Antifungal Therapy -- 10.4.1 Lipid Nanoparticles -- 10.4.2 Liposome -- 10.4.3 Transfersomes -- 10.4.4 Transethosomes -- 10.4.5 Solid Lipid Nanoparticles (SLN) -- 10.4.6 Nanostructured Lipid Carriers (NLC) -- 10.4.7 Polymer Lipid Hybrid Nanoparticles (PLN) -- 10.4.8 Polymeric Nanoparticles -- 10.4.9 Microsponge and Nanosponge Systems -- 10.4.10 Polymeric Micelles -- 10.4.11 Polymersomes -- 10.4.12 Dendrimers -- 10.4.13 Metallic Nanoparticles -- 10.5 Other Drug Delivery Systems -- 10.5.1 Niosomes -- 10.5.2 Spanlastics -- 10.5.3 Microemulsions and Nanoemulsions -- 10.5.4 Silicon Dioxide Nanoparticles -- 10.6 Conclusion -- References -- Chapter 11 Nano-Based Drug Delivery in Eliminating Tuberculosis -- 11.1 Introduction -- 11.1.1 Latent and Active Tuberculosis -- 11.1.2 Multidrug-Resistant Tuberculosis (MDR-TB) -- 11.1.3 Extensively Drug-Resistant TB -- 11.2 Antitubercular Therapy -- 11.3 Therapies Based on Nanotechnology -- 11.3.1 Nanoparticles for Anti-TB Therapy -- 11.3.2 Advantages and Disadvantages of Nanoparticles -- 11.3.3 Types of Nanoparticles and Their Characteristics -- 11.3.3.1 TB Dendrimers -- 11.3.3.2 Cyclodextrins -- 11.3.3.3 Polymeric Micelles -- 11.3.3.4 Liposomes -- 11.3.3.5 Nanoemulsions -- 11.3.3.6 Solid Lipid Nanoparticles -- 11.3.3.7 Niosomes -- 11.3.3.8 Polymeric Nanoparticles -- 11.4 Routes of Administration of Nanoparticles -- 11.4.1 Oral Administration of Nanoparticles -- 11.4.2 Inhalational Administration of Nanoparticles. 11.4.3 Intravenous Administration of Nanoparticles. |
| Record Nr. | UNINA-9910877982103321 |
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2023.2 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Architectural Graphic Standards / / AmericanInstituteofArchitects, HedgesKeithE.著
| Architectural Graphic Standards / / AmericanInstituteofArchitects, HedgesKeithE.著 |
| Edizione | [12th ed., Student ed.] |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2017.5 |
| Descrizione fisica | 1 online resource (691 pages) : illustrations |
| Disciplina | 690 |
| Collana | Ramsey/Sleeper Architectural Graphic Standards Series |
| Soggetto topico |
Architectural drawing - Standards
Building - Details - Drawings - Standards Standards, Engineering |
| ISBN |
1-119-31274-4
1-119-31273-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Record Nr. | UNINA-9910795954603321 |
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2017.5 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Introduction to Wireless Sensor Networks / / ForsterAnna著
| Introduction to Wireless Sensor Networks / / ForsterAnna著 |
| Autore | Förster Anna |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2016.8 |
| Descrizione fisica | 1 online resource (203 p.) |
| Disciplina | 681.2 |
| Soggetto topico | Wireless sensor networks |
| ISBN |
9781119345343
1119345340 9781119079934 1119079934 9781119079958 1119079950 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Nota di contenuto |
How to Use This Book xiii -- 1 What are Wireless Sensor Networks? 1 -- 1.1 Wireless Sensor Networks, 1 -- 1.2 Sample Applications Around the World, 3 -- 1.3 Types of Wireless Sensor Networks, 7 -- Summary, 10 -- Further Reading, 10 -- 2 Anatomy of a Sensor Node 11 -- 2.1 Hardware Components, 11 -- 2.2 Power Consumption, 13 -- 2.3 Operating Systems and Concepts, 15 -- 2.3.1 Memory Management, 17 -- 2.3.2 Interrupts, 23 -- 2.3.3 Tasks, Threads, and Events, 24 -- 2.4 Simulators, 26 -- 2.5 Communication Stack, 28 -- 2.5.1 Sensor Network Communication Stack, 28 -- 2.5.2 Protocols and Algorithms, 30 -- Anatomy of a Sensor Node: Summary, 30 -- Further Reading, 30 -- 3 Radio Communications 33 -- 3.1 Radio Waves and Modulation/Demodulation, 33 -- 3.2 Properties of Wireless Communications, 36 -- 3.2.1 Interference and Noise, 37 -- 3.2.2 Hidden Terminal Problem, 38 -- 3.2.3 Exposed Terminal Problem, 39 -- 3.3 Medium Access Protocols, 39 -- 3.3.1 Design Criteria for Medium Access Protocols, 41 -- 3.3.2 Time Division Multiple Access, 42 -- 3.3.3 Carrier Sense Multiple Access, 45 -- 3.3.4 Sensor MAC, 48 -- 3.3.5 Berkeley MAC, 50 -- 3.3.6 Optimizations of B-MAC, 51 -- 3.3.7 Other Protocols and Trends, 51 -- Radio Communications: Summary, 53 -- Questions and Exercises, 53 -- Further Reading, 54 -- 4 Link Management 57 -- 4.1 Wireless Links Introduction, 57 -- 4.2 Properties of Wireless Links, 59 -- 4.2.1 Links and Geographic Distance, 59 -- 4.2.2 Asymmetric Links, 60 -- 4.2.3 Link Stability and Burstiness, 61 -- 4.3 Error Control, 62 -- 4.3.1 Backward Error Control, 62 -- 4.3.2 Forward Error Control, 63 -- 4.4 Naming and Addressing, 64 -- 4.4.1 Naming, 64 -- 4.4.2 Addressing, 65 -- 4.4.3 Assignment of Addresses and Names, 65 -- 4.4.4 Using Names and Addresses, 66 -- 4.5 Link Estimation Protocols, 66 -- 4.5.1 Design Criteria, 66 -- 4.5.2 Link Quality Based, 67 -- 4.5.3 Delivery Rate Based, 68 -- 4.5.4 Passive and Active Estimators, 69 -- 4.5.5 Collection Tree Protocol, 69 -- 4.6 Topology Control, 71.
4.6.1 Centralized Topology Control, 71 -- 4.6.2 Distributed Topology Control, 72 -- Link Management: Summary, 73 -- Questions and Exercises, 73 -- Further Reading, 74 -- 5 Multi-Hop Communications 77 -- 5.1 Routing Basics, 77 -- 5.2 Routing Metrics, 80 -- 5.2.1 Location and Geographic Vicinity, 80 -- 5.2.2 Hops, 81 -- 5.2.3 Number of Retransmissions, 82 -- 5.2.4 Delivery Delay, 83 -- 5.3 Routing Protocols, 84 -- 5.3.1 Full-Network Broadcast, 85 -- 5.3.2 Location-Based Routing, 87 -- 5.3.3 Directed Diffusion, 90 -- 5.3.4 Collection Tree Protocol, 92 -- 5.3.5 Zigbee, 94 -- Multi-Hop Communications: Summary, 95 -- Questions and Exercises, 96 -- Further Reading, 96 -- 6 Data Aggregation and Clustering 99 -- 6.1 Clustering Techniques, 99 -- 6.1.1 Random Clustering, 101 -- 6.1.2 Nearest Sink, 102 -- 6.1.3 Geographic Clustering, 103 -- 6.1.4 Clustering Summary, 104 -- 6.2 In-Network Processing and Data Aggregation, 104 -- 6.2.1 Compression, 104 -- 6.2.2 Statistical Techniques, 107 -- 6.3 Compressive Sampling, 109 -- Data Aggregation and Clustering: Summary, 110 -- Questions and Exercises, 111 -- Further Reading, 111 -- 7 Time Synchronization 113 -- 7.1 Clocks and Delay Sources, 113 -- 7.2 Requirements and Challenges, 114 -- 7.3 Time Synchronization Protocols, 117 -- 7.3.1 Lightweight Tree Synchronization, 117 -- 7.3.2 Reference Broadcast Synchronization, 118 -- 7.3.3 NoTime Protocol, 118 -- Time Synchronization: Summary, 120 -- Questions and Exercises, 121 -- Further Reading, 121 -- 8 Localization Techniques 123 -- 8.1 Localization Challenges and Properties, 123 -- 8.1.1 Types of Location Information, 124 -- 8.1.2 Precision Against Accuracy, 125 -- 8.1.3 Costs, 125 -- 8.2 Pre-Deployment Schemes, 126 -- 8.3 Proximity Schemes, 126 -- 8.4 Ranging Schemes, 128 -- 8.4.1 Triangulation, 129 -- 8.4.2 Trilateration, 129 -- 8.5 Range-Based Localization, 129 -- 8.6 Range-Free Localization, 130 -- 8.6.1 Hop-Based Localization, 130 -- 8.6.2 Point in Triangle (PIT), 131 -- Localization: Summary, 132. Questions and Exercises, 133 -- Further Reading, 133 -- 9 Sensing Techniques 135 -- 9.1 Types of Sensors, 135 -- 9.2 Sensing Coverage, 136 -- 9.3 High-Level Sensors, 137 -- 9.4 Special Case: The Human As a Sensor, 138 -- 9.5 Actuators, 138 -- 9.6 Sensor Calibration, 139 -- 9.7 Detecting Errors, 140 -- Sensing Techniques: Summary, 141 -- Questions and Exercises, 141 -- 10 Designing and Deploying WSN Applications 143 -- 10.1 Early WSN Deployments, 143 -- 10.1.1 Murphy Loves Potatoes, 144 -- 10.1.2 Great Duck Island, 144 -- 10.2 General Problems, 145 -- 10.2.1 Node Problems, 146 -- 10.2.2 Link/Path Problems, 147 -- 10.2.3 Global Problems, 148 -- 10.3 General Testing and Validation, 149 -- 10.4 Requirements Analysis, 151 -- 10.4.1 Analyzing the Environment, 151 -- 10.4.2 Analyzing Lifetime and Energy Requirements, 153 -- 10.4.3 Analyzing Required Data, 153 -- 10.4.4 Analyzing User Expectations, 154 -- 10.5 The Top-Down Design Process, 154 -- 10.5.1 The Network, 154 -- 10.5.2 The Node Neighborhood, 155 -- 10.5.3 The Node, 156 -- 10.5.4 Individual Components of the Node, 156 -- 10.6 Bottom-Up Implementation Process, 157 -- 10.6.1 Individual Node-Level Modules, 158 -- 10.6.2 The Node As an Entity, 159 -- 10.6.3 The Network As an Entity, 159 -- Designing and Deploying WSN Applications: Summary, 160 -- Further Reading, 160 -- 11 Summary and Outlook 163 -- Index 167. |
| Record Nr. | UNINA-9910154672703321 |
Förster Anna
|
||
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2016.8 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Kitchen and Bath Lighting : Concept, Design, Light / / BlitzerDan, MackayTammy, NKBA(NationalKitchenandBathAssociation)著
| Kitchen and Bath Lighting : Concept, Design, Light / / BlitzerDan, MackayTammy, NKBA(NationalKitchenandBathAssociation)著 |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2015.5 |
| Descrizione fisica | 1 online resource (291 pages) : color illustrations |
| Disciplina | 621.32/2 |
| Collana | NKBA Professional Resource Library |
| Soggetto topico |
Bathrooms - Design and construction
Dwellings - Lighting Kitchens - Design and construction |
| ISBN |
1-119-12455-7
1-119-12456-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Record Nr. | UNINA-9910795820603321 |
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2015.5 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neuropsychology for Occupational Therapists : Cognition in Occupational Performance / / MaskillLinda, TempestStephanie編
| Neuropsychology for Occupational Therapists : Cognition in Occupational Performance / / MaskillLinda, TempestStephanie編 |
| Autore | Maskill Linda |
| Edizione | [4th ed.] |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2017.3 |
| Descrizione fisica | 1 online resource (217 pages) : illustrations |
| Disciplina | 616.80475 |
| Soggetto topico |
Neuropsychology
Occupational therapy |
| ISBN |
1-78785-075-7
1-119-55703-8 1-118-71131-9 1-118-71130-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Nota di contenuto | Occupation and cognitive rehabilitation / Stephanie Tempest and Linda Maskill -- Assessment, and measuring change / Linda Maskill and Stephanie Tempest -- Intervention for cognitive impairments, and evaluating outcomes / Linda Maskill and Stephanie Tempest -- Cognition : methods and processes / Linda Maskill and Stephanie Tempest -- Attention / Richard Jefferson and Linda Maskill -- Visual perception, recognition and agnosia / Linda Maskill and June Grieve -- Complex perceptual functions : body scheme and agnosia, constructional skills and neglect / Stephanie Tempest and Linda Maskill -- Memory / Tess Baird and Linda Maskill -- Purposeful movement and apraxia / Stephanie Tempest -- Executive functions / Sacha Hildebrandt -- Cognitive function in the general population : maintaining cognitive health in later years / Linda Maskill. |
| Record Nr. | UNINA-9910162922703321 |
Maskill Linda
|
||
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2017.3 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Rutter's Child and Adolescent Psychiatry / / ThaparAnita[ほか]編
| Rutter's Child and Adolescent Psychiatry / / ThaparAnita[ほか]編 |
| Edizione | [6th ed.] |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2015.7 |
| Descrizione fisica | 1 online resource (1098 p.) |
| Disciplina |
618.92
618.9289 |
| Soggetto topico |
Psiquiatría infantil
Psiquiatria de l'adolescència Child psychiatry Adolescent psychiatry |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
1-118-38189-0
1-118-38195-5 1-118-38193-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Nota di contenuto | Cover -- Title Page -- Copyright -- Contents -- List of contributors -- Foreword -- Preface -- Part I Conceptual issues and research approaches -- A Developmental psychopathology -- Chapter 1 Development and psychopathology: a life course perspective -- Introduction -- Methodological considerations -- Research designs -- Retrospective and prospective measures -- Statistical methods for longitudinal research -- Childhood-adulthood continuities -- Antisocial behavior -- Depression -- Anxiety disorders -- Neurodevelopmental disorders -- Heterotypic transitions and psychopathological progressions -- Long-term effects of early experience. ConclusionsReferences -- Chapter 2 Diagnosis, diagnostic formulations, and classification -- Introduction -- Definition -- Clinical and research classifications -- Biomarkers and neural signatures -- Dimensions and categories -- The supposed separateness of syndromes -- Validation of diagnostic categories -- Age trends and sex differences -- Familiality and genetics -- Psychosocial correlates -- Long-term course -- Drug response -- Cognitive impairments and developmental delay -- Biology -- Validating criteria -- "Lumping" or "splitting" -- Threshold for diagnosis -- Separate classifications in different countries. Staging or severity of disordersDSM-5 and ICD-11 -- References -- Chapter 3 Neurodevelopmental disorders -- The classification of neurodevelopmental disorders -- Concepts of maturational lag and of plateaus in developmental progress -- Concept of comorbidity and patterns of co-occurrence within the group of neurodevelopmental disorders -- The co-occurrence of different neurodevelopmental disorders due to shared risks and biological characteristics -- Genetics -- Environmental influences -- Shared biological and neural characteristics -- Sex differences. Does neurodevelopmental impairment have the same meaning in all disorders?Clinical value of neurodevelopmental impairment concepts -- Acknowledgments -- References -- Chapter 4 Conceptual issues and empirical challenges in the disruptive behavior disorders -- The scope of this chapter -- What is the phenotype? -- The starting point: well-replicated findings -- What do we need to explain? -- Unraveling risks for disruptive behavior problems -- Anger-proneness in interaction with adverse parenting-a high reactive pathway -- Lack of responsiveness to others' distress-a low reactive pathway. Adaptations to threat over development-from high reactivity to low reactivityPeer influences -- Sex differences -- "Comorbidity" -- Adolescent onset of disruptive and antisocial behaviors -- Conclusions -- References -- Chapter 5 Emotion, emotion regulation and emotional disorders: conceptual issues for clinicians and neuroscientists -- Terms and definitions -- An imaginary experiment -- The clinician's approach: description and first-person account -- A neuroscientist's approach: distinguishing emotions from feelings -- More from the neuroscientist: context, and interpretation versus reward and punishment. |
| Record Nr. | UNINA-9910131256303321 |
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2015.7 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Thermodynamics of Pharmaceutical Systems : An Introduction for Students of Pharmacy / / ConnorsKennethA.著
| Thermodynamics of Pharmaceutical Systems : An Introduction for Students of Pharmacy / / ConnorsKennethA.著 |
| Autore | Connors Kenneth A. |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2002.9 |
| Descrizione fisica | 1 online resource (358 p.) |
| Disciplina |
615.19
615/.19 |
| Soggetto topico |
Pharmaceutical chemistry
Thermodynamics |
| ISBN |
1-280-36679-6
9786610366798 0-470-30556-8 1-60119-515-X 0-471-23492-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Nota di contenuto |
THERMODYNAMICS OF PHARMACEUTICAL SYSTEMS; CONTENTS; PREFACE; I BASIC THERMODYNAMICS; 1 Energy and the First Law of Thermodynamics; 1.1. Fundamental Concepts; 1.2. The First Law of Thermodynamics; 1.3. The Enthalpy; 2 The Entropy Concept; 2.1. The Entropy Defined; 2.2. The Second Law of Thermodynamics; 2.3. Applications of the Entropy Concept; 3 The Free Energy; 3.1. Properties of the Free Energy; 3.2. The Chemical Potential; 4 Equilibrium; 4.1. Conditions for Equilibrium; 4.2. Physical Processes; 4.3. Chemical Equilibrium; II THERMODYNAMICS OF PHYSICAL PROCESSES
5 Introduction to Physical Processes5.1. Scope; 5.2. Concentration Scales; 5.3. Standard States; 6 Phase Transformations; 6.1. Pure Substances; 6.2. Multicomponent Systems; 7 Solutions of Nonelectrolytes; 7.1. Ideal Solutions; 7.2. Nonideal Solutions; 7.3. Partitioning between Liquid Phases; 8 Solutions of Electrolytes; 8.1. Coulombic Interaction and Ionic Dissociation; 8.2. Mean Ionic Activity and Activity Coefficient; 8.3. The Debye-Hückel Theory; 9 Colligative Properties; 9.1. Boiling Point Elevation; 9.2. Freezing Point Depression; 9.3. Osmotic Pressure; 9.4. Isotonicity Calculations 10 Solubility10.1. Solubility as an Equilibrium Constant; 10.2. The Ideal Solubility; 10.3. Temperature Dependence of the Solubility; 10.4. Solubility of Slightly Soluble Salts; 10.5. Solubilities of Nonelectrolytes: Further Issues; 11 Surfaces and Interfaces; 11.1. Thermodynamic Properties; 11.2. Adsorption; III THERMODYNAMICS OF CHEMICAL PROCESSES; 12 Acid-Base Equilibria; 12.1. Acid-Base Theory; 12.2. pH Dependence of Acid-Base Equilibria; 12.3. Calculation of Solution pH; 12.4. Acid-Base Titrations; 12.5. Aqueous Solubility of Weak Acids and Bases; 12.6. Nonaqueous Acid-Base Behavior 12.7. Acid-Base Structure and Strength13 Electrical Work; 13.1. Introduction; 13.2. Oxidation-Reduction Reactions; 13.3. Electrochemical Cells; 13.4. pH Measurement; 13.5. Ion-Selective Membrane Electrodes; 14 Noncovalent Binding Equilibria; 14.1. Introduction; 14.2. The Noncovalent Interactions; 14.3. Binding Models; 14.4. Measurement of Binding Constants; APPENDIXES; A Physical Constants; B Review of Mathematics; B.1. Introduction; B.2. Logarithms and Exponents; B.3. Algebraic and Graphical Analysis; B.4. Dealing with Change; B.5. Statistical Treatment of Data; B.6. Dimensions and Units ANSWERS TO PROBLEMSBIBLIOGRAPHY; INDEX |
| Record Nr. | UNINA-9910830694103321 |
Connors Kenneth A.
|
||
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2002.9 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Thermodynamics of Pharmaceutical Systems : An Introduction for Students of Pharmacy / / ConnorsKennethA.著
| Thermodynamics of Pharmaceutical Systems : An Introduction for Students of Pharmacy / / ConnorsKennethA.著 |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2002.9 |
| Descrizione fisica | 1 online resource (358 p.) |
| Disciplina |
615.19
615/.19 |
| Soggetto topico |
Pharmaceutical chemistry
Thermodynamics |
| ISBN |
9786610366798
9781280366796 1280366796 9780470305560 0470305568 9781601195159 160119515X 9780471234920 0471234923 |
| Classificazione |
499.3
QC 311 615/.19 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Nota di contenuto |
THERMODYNAMICS OF PHARMACEUTICAL SYSTEMS; CONTENTS; PREFACE; I BASIC THERMODYNAMICS; 1 Energy and the First Law of Thermodynamics; 1.1. Fundamental Concepts; 1.2. The First Law of Thermodynamics; 1.3. The Enthalpy; 2 The Entropy Concept; 2.1. The Entropy Defined; 2.2. The Second Law of Thermodynamics; 2.3. Applications of the Entropy Concept; 3 The Free Energy; 3.1. Properties of the Free Energy; 3.2. The Chemical Potential; 4 Equilibrium; 4.1. Conditions for Equilibrium; 4.2. Physical Processes; 4.3. Chemical Equilibrium; II THERMODYNAMICS OF PHYSICAL PROCESSES
5 Introduction to Physical Processes5.1. Scope; 5.2. Concentration Scales; 5.3. Standard States; 6 Phase Transformations; 6.1. Pure Substances; 6.2. Multicomponent Systems; 7 Solutions of Nonelectrolytes; 7.1. Ideal Solutions; 7.2. Nonideal Solutions; 7.3. Partitioning between Liquid Phases; 8 Solutions of Electrolytes; 8.1. Coulombic Interaction and Ionic Dissociation; 8.2. Mean Ionic Activity and Activity Coefficient; 8.3. The Debye-Hückel Theory; 9 Colligative Properties; 9.1. Boiling Point Elevation; 9.2. Freezing Point Depression; 9.3. Osmotic Pressure; 9.4. Isotonicity Calculations 10 Solubility10.1. Solubility as an Equilibrium Constant; 10.2. The Ideal Solubility; 10.3. Temperature Dependence of the Solubility; 10.4. Solubility of Slightly Soluble Salts; 10.5. Solubilities of Nonelectrolytes: Further Issues; 11 Surfaces and Interfaces; 11.1. Thermodynamic Properties; 11.2. Adsorption; III THERMODYNAMICS OF CHEMICAL PROCESSES; 12 Acid-Base Equilibria; 12.1. Acid-Base Theory; 12.2. pH Dependence of Acid-Base Equilibria; 12.3. Calculation of Solution pH; 12.4. Acid-Base Titrations; 12.5. Aqueous Solubility of Weak Acids and Bases; 12.6. Nonaqueous Acid-Base Behavior 12.7. Acid-Base Structure and Strength13 Electrical Work; 13.1. Introduction; 13.2. Oxidation-Reduction Reactions; 13.3. Electrochemical Cells; 13.4. pH Measurement; 13.5. Ion-Selective Membrane Electrodes; 14 Noncovalent Binding Equilibria; 14.1. Introduction; 14.2. The Noncovalent Interactions; 14.3. Binding Models; 14.4. Measurement of Binding Constants; APPENDIXES; A Physical Constants; B Review of Mathematics; B.1. Introduction; B.2. Logarithms and Exponents; B.3. Algebraic and Graphical Analysis; B.4. Dealing with Change; B.5. Statistical Treatment of Data; B.6. Dimensions and Units ANSWERS TO PROBLEMSBIBLIOGRAPHY; INDEX |
| Record Nr. | UNINA-9911019719403321 |
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2002.9 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Veterinary Embryology / / McGeadyT.A.[ほか]著
| Veterinary Embryology / / McGeadyT.A.[ほか]著 |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2017.1 |
| Descrizione fisica | 1 online resource (401 pages) : illustrations |
| Disciplina | 636.089264 |
| Soggetto topico | Veterinary embryology |
| ISBN |
1-118-94060-1
1-118-94059-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | und |
| Record Nr. | UNINA-9910162922603321 |
| ワイリー・パブリッシング・ジャパン/ワイリー・ブラックウェル, 2017.1 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||